Skip to Main Content

Author Details

Seong Il Seo
Samsung Medical Center, Sungkyunkwan University School of Medicine
1999
224
32
PMIDPaper TitleJournal TitlePublished Year
37118959Nomogram Using Prostate Health Index for Predicting Prostate Cancer in the Gray Zone: Prospective, Multicenter Study.World J Mens Health2024
38000052Impact of urinary diversion type on urethral recurrence following radical cystectomy for bladder cancer: propensity score matched and weighted analyses of retrospective cohort.Int J Surg2024
36254631Repression of SLC22A3 by the AR-V7/YAP1/TAZ axis in enzalutamide-resistant castration-resistant prostate cancer.FEBS J2023
37668199How far has robot-assisted partial nephrectomy reached?Investig Clin Urol2023
37745907Prostate-specific antigen kinetics in hypofractionated radiation therapy alone for intermediate- and high-risk localized prostate cancer.Prostate Int2023
37509551Comparison of Prostate-Specific Antigen and Its Density and Prostate Health Index and Its Density for Detection of Prostate Cancer.Biomedicines2023
37444526Novel Multiparametric Magnetic Resonance Imaging-Based Deep Learning and Clinical Parameter Integration for the Prediction of Long-Term Biochemical Recurrence-Free Survival in Prostate Cancer after Radical Prostatectomy.Cancers (Basel)2023
37409092Combination of multiparametric magnetic resonance imaging and transperineal template-guided mapping prostate biopsy to determine potential candidates for focal therapy.Prostate Int2023
37376735Risk factors for prostate-specific antigen persistence in pT3aN0 prostate cancer after robot-assisted laparoscopic radical prostatectomy: a retrospective study.J Yeungnam Med Sci2023
36716293CEACAM1 Marks Highly Suppressive Intratumoral Regulatory T Cells for Targeted Depletion Therapy.Clin Cancer Res2023
36835404Fat Loss in Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.Int J Mol Sci2023
36929129New transperineal ultrasound-guided biopsy for men in whom PSA is increasing after Miles' operation.Insights Imaging2023
36167777Chromosomal Instability in Cell-free DNA as a Prognostic Biomarker of Metastatic Hormone-sensitive Prostate Cancer Treated with Androgen Deprivation Therapy.Eur Urol Focus2023
35141158TRUS-Guided Target Biopsy for a PI-RADS 3-5 Index Lesion to Reduce Gleason Score Underestimation: A Propensity Score Matching Analysis.Front Oncol2022
35510096Utility of multiple core biopsies during transperineal template-guided mapping biopsy for patients with large prostates and PI-RADS 1-2 on multiparametric magnetic resonance imaging.Prostate Int2022
35675311Correction: Biochemical recurrence after radical prostatectomy according to nadir prostate specific antigen value.PLoS One2022
35574412A Retrospective Study of First-Line Therapy Involving Immune Checkpoint Inhibitors in Patients With Poor Risk Metastatic Renal Cell Carcinoma.Front Oncol2022
35626196Utility of Contemporary Health Screening in the Diagnosis of Bladder Cancer.Diagnostics (Basel)2022
35626101Robotic Radical Nephroureterectomy with Bladder Cuff Excision for Upper Tract Urothelial Carcinoma: A Trend Analysis of Utilization and a Comparative Study.Cancers (Basel)2022
35625960Molecular Subtypes Based on Genomic and Transcriptomic Features Correlate with the Responsiveness to Immune Checkpoint Inhibitors in Metastatic Clear Cell Renal Cell Carcinoma.Cancers (Basel)2022
36293494Cabozantinib-Loaded PLGA Nanoparticles: A Potential Adjuvant Strategy for Surgically Resected High-Risk Non-Metastatic Renal Cell Carcinoma.Int J Mol Sci2022
36291981A Comparison of Functional and Oncologic Outcomes between Partial Nephrectomy and Radiofrequency Ablation in Patients with Chronic Kidney Disease after Propensity Score Matching.Diagnostics (Basel)2022
36077710Clinical Utility of Prostate Health Index for Diagnosis of Prostate Cancer in Patients with PI-RADS 3 Lesions.Cancers (Basel)2022
33857365Risk Factors and Patterns of Locoregional Recurrence after Radical Nephrectomy for Locally Advanced Renal Cell Carcinoma.Cancer Res Treat2022
33047324Metastatic renal cell carcinoma to the pancreas: Clinical features and treatment outcome.J Surg Oncol2021
33923583Pattern of Tumor-Infiltrating Lymphocytes in Mixed Epithelial and Stromal Tumor of the Kidney: A Review of Five Cases.Cells2021
33692449Potential of circulating tumor DNA as a predictor of therapeutic responses to immune checkpoint blockades in metastatic renal cell carcinoma.Sci Rep2021
33837237Comparison of oncologic and functional outcomes between radical nephroureterectomy and segmental ureterectomy for upper urinary tract urothelial carcinoma.Sci Rep2021
33527588Targeted therapy response in early versus late recurrence of renal cell carcinoma after surgical treatment: A propensity score-matched study using the Korean Renal Cancer Study Group database.Int J Urol2021
33660451Genomic mutation profiling using liquid biopsy in Korean patients with prostate cancer: Circulating tumor DNA mutation predicts the development of castration resistance.Investig Clin Urol2021
33916347Assessment of Agreement between Two Difference Prostate-Specific Antigen Assay Modalities.Biology (Basel)2021
34944964Prognostic Impact of Sarcopenia in Patients with Metastatic Hormone-Sensitive Prostate Cancer.Cancers (Basel)2021
34753990ISL1 promotes enzalutamide resistance in castration-resistant prostate cancer (CRPC) through epithelial to mesenchymal transition (EMT).Sci Rep2021
34753938Usefulness of MRI targeted prostate biopsy for detecting clinically significant prostate cancer in men with low prostate-specific antigen levels.Sci Rep2021
34692504Conditional Intravesical Recurrence-Free Survival Rate After Radical Nephroureterectomy With Bladder Cuff Excision for Upper Tract Urothelial Carcinoma.Front Oncol2021
34397846Prognostic factors for overall survival in patients with clear cell metastatic renal cell carcinoma: Model development and external validation with Memorial Sloan Kettering Cancer Center model and the international metastatic renal cell carcinoma database consortium model.Medicine (Baltimore)2021
34839812A prospective phase-II trial of biweekly docetaxel plus androgen deprivation therapy in patients with previously-untreated metastatic castration-naïve prostate cancer.BMC Cancer2021
34768437Preoperative versus Postoperative Compensation of the Contralateral Normal Kidney in Patients Treated with Radical Nephrectomy for Renal Cell Carcinoma.J Clin Med2021
34768322The Role of Prostate Combination Biopsy Consisting of Targeted and Additional Systematic Biopsy.J Clin Med2021
33939714Biochemical recurrence after radical prostatectomy according to nadir prostate specific antigen value.PLoS One2021
34071865Renal Cell Carcinoma-Infiltrating CD3<sup>low</sup> Vγ9Vδ1 T Cells Represent Potentially Novel Anti-Tumor Immune Players.Curr Issues Mol Biol2021
34262353Can Prostate-Specific Antigen Density Be an Index to Distinguish Patients Who Can Omit Repeat Prostate Biopsy in Patients with Negative Magnetic Resonance Imaging?Cancer Manag Res2021
34235097Comparison of Risk Factors for the Development of Proteinuria After Radical Nephrectomy for Renal Cell Carcinoma.Res Rep Urol2021
33421984Effects of Complete Bladder Cuff Removal on Oncological Outcomes Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma.Cancer Res Treat2021
31621405Comparison by Pentafecta Criteria of Transperitoneal and Retroperitoneal Robotic Partial Nephrectomy for Large Renal Tumors.J Endourol2020
31987989Functions of human liver CD69<sup>+</sup>CD103<sup>-</sup>CD8<sup>+</sup> T cells depend on HIF-2α activity in healthy and pathologic livers.J Hepatol2020
33193883Prognostic Impact of Bone Metastasis on Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma Treated by First Line Tyrosine Kinase Inhibitors: A Propensity-Score Matching Analysis.J Cancer2020
33135403Correlation between Gleason score distribution and Prostate Health Index in patients with prostate-specific antigen values of 2.5-10 ng/mL.Investig Clin Urol2020
33107227Strategy for Prostate Cancer Patients with Low Prostate Specific Antigen Level (2.5 to 4.0 ng/mL).J Korean Med Sci2020
33102394Detection of prostate cancer using prostate imaging reporting and data system score and prostate-specific antigen density in biopsy-naive and prior biopsy-negative patients.Prostate Int2020
  • 1 - 50 of 224

Recommended Authors

Mayo Clinic
Career Start Year 2017
Number of shared co-authors 0
institute of urology
Career Start Year 2016
Number of shared co-authors 0
Rutgers Cancer Institute of New Jersey
Career Start Year 2016
Number of shared co-authors 1
Yale School of Medicine
Career Start Year 2015
Number of shared co-authors 0
Institute of Cancer Prevention and Treatment, Harbin Medical University
Career Start Year 2015
Number of shared co-authors 0
Careggi University Hospital
Career Start Year 2014
Number of shared co-authors 0
Glickman Urological & Kidney Institute, Cleveland Clinic
Career Start Year 2013
Number of shared co-authors 0
University of North Carolina School of Medicine
Career Start Year 2012
Number of shared co-authors 0
Institute of Urologic Oncology, University of California los angeles
Career Start Year 2010
Number of shared co-authors 0
Columbia University Medical Center
Career Start Year 2010
Number of shared co-authors 0
Brady Urological Institute, Johns Hopkins University School of Medicine
Career Start Year 2010
Number of shared co-authors 0
Yale School of Medicine
Career Start Year 2008
Number of shared co-authors 0
David Geffen School of Medicine, University of California los angeles
Career Start Year 2008
Number of shared co-authors 0
University of California San Diego
Career Start Year 2005
Number of shared co-authors 0
University of Florida
Career Start Year 2005
Number of shared co-authors 0
University of Washington Medical Center
Career Start Year 2005
Number of shared co-authors 0
Universitatsklinikum Hamburg-Eppendorf
Career Start Year 2004
Number of shared co-authors 0
Xiangya Hospital of Central South University
Career Start Year 2003
Number of shared co-authors 1
The Mayo Clinic
Career Start Year 2001
Number of shared co-authors 0
David Geffen School of Medicine at university of california los angeles
Career Start Year 2001
Number of shared co-authors 0
Mayo Clinic
Career Start Year 2000
Number of shared co-authors 0
university of california san diego School of Medicine
Career Start Year 2000
Number of shared co-authors 1
university of california san diego School of Medicine
Career Start Year 1998
Number of shared co-authors 1
University of Michigan ann arbor
Career Start Year 1997
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 0
University of Illinois at Chicago
Career Start Year 1996
Number of shared co-authors 0
New York-Presbyterian Hospital
Career Start Year 1994
Number of shared co-authors 0
Princess Margaret Cancer Centre, University Health Network and University of Toronto
Career Start Year 1993
Number of shared co-authors 0
Eberhard Karls University of Tubingen
Career Start Year 1984
Number of shared co-authors 0
University Hospitals Leuven
Career Start Year 1981
Number of shared co-authors 0

Collaborators

Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 162
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 154
Seoul National University Hospital, Seoul National University College of Medicine
Co-authored papers 24
Seoul National University Hospital, Seoul National University College of Medicine
Co-authored papers 21
Yonsei University College of Medicine, Severance Hospital
Co-authored papers 15
Seoul National University Bundang Hospital
Co-authored papers 12
Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea
Co-authored papers 9
James Buchanan Brady Urological Institute, Johns Hopkins School of Medicine
Co-authored papers 8
Asan Medical Center, University of Ulsan College of Medicine
Co-authored papers 7
Seoul National University Bundang Hospital
Co-authored papers 7
Asan Medical Center, University of Ulsan College of Medicine
Co-authored papers 5
Samsung Genome Institute, Samsung Medical Center
Co-authored papers 5
Yonsei University College of Medicine and Gangnam Severance Hospital
Co-authored papers 4
Center for Nanophase Materials Sciences, Oak Ridge National Laboratory
Co-authored papers 3
Samsung Medical Center, Sungkyunkwan University School
Co-authored papers 3
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 2
The Catholic University of Korea College of Medicine
Co-authored papers 2
College of Science & Industry Convergence, Ewha Womans University
Co-authored papers 2
Cancer Stem Cell Research Center, Samsung Biomedical Research Institute
Co-authored papers 1
College of Medicine, The Catholic University of Korea
Co-authored papers 1
Gangnam Severance Hospital
Co-authored papers 1
College of Medicine, Catholic University of Korea
Co-authored papers 1
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 1
Research Institute, National Cancer Center
Co-authored papers 1
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 1
USC Norris Comprehensive Cancer Center
Co-authored papers 1
University of Texas Health Science Center at Houston
Co-authored papers 1
Touro College of Osteopathic Medicine
Co-authored papers 1
Seoul National University College of Medicine
Co-authored papers 1
Co-authored papers 1